What pharmaceutical companies are still out there that it would be advantageous for Pfizer to merge or acquire with and how would it help them in terms of any product diversification and/or expansion in a certain drug portfolio? What should be done to make sure the merger or acquisition goes smoothly? This is a hypothetical situation.
Categories: